Synapse Open Synapse
Biology

STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive

STAT News · · 1 min read

Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:

Latest from STAT News